Artificial Cells, Nanomedicine, and Biotechnology (Jan 2021)

Oxidative biotransformation of stemofoline alkaloids

  • Manlika Phaya,
  • Sirinrat Chalom,
  • Kornkanok Ingkaninan,
  • Kontad Ounnunkad,
  • Nopakarn Chandet,
  • Stephen G. Pyne,
  • Pitchaya Mungkornasawakul

DOI
https://doi.org/10.1080/21691401.2021.1883044
Journal volume & issue
Vol. 49, no. 1
pp. 166 – 172

Abstract

Read online

Biotransformations of stemofoline (1a), (2′S)-hydroxystemofoline (2a), (11Z)-1′,2′-didehydrostemofoline (3a) and stemocurtisine (4) were studied through fermentation with Cunninghamella elegans TISTR 3370. Three new stemofoline derivatives; (6 R)-hydroxystemofoline (1b), (2′S, 6 R)-dihydroxystemofoline (2b) and (11Z,6R)-1′,2′-didehydro-6-hydroxystemofoline (3b), together with the known compound 1′,2′-didehydrostemofoline-N-oxide (3c), were produced by C-hydroxylation and N-oxidation reactions. Stemocurtisine was not biotransformed under these conditions. The transformed product 1b was four times more potent (IC50 = 11.01 ± 1.49 µM) than its precursor 1a (IC50 = 45.1 ± 5.46 µM) as an inhibitor against acetylcholinesterase.

Keywords